Exactly. It’s what I keep saying and they keep trying to point elsewhere, but that’s where I am and not unusual for a promising drug pre-approval to have dropped a lot from an initial offer decades ago, to recover as it approaches finalization if a drug application and approval, but for me the last 5 years have been very positive and when compared to the NBI and XBI, incredibly positive.